Consolidated Statement of Operation Statement (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Net sales and revenues        
Sales of goods $ 1,440 $ 1,776 $ 4,479 $ 4,213
Contract research and service revenues 2,301 2,378 7,193 6,753
Total net sales and revenues 3,741 4,154 11,672 10,966
Cost of sales and revenues        
Cost of goods sold 1,418 1,868 5,262 5,561
Cost of contract research and services 1,002 1,101 3,888 3,482
Total cost of sales and revenues 2,420 2,969 9,150 9,043
Gross margin 1,321 1,185 2,522 1,923
Operating expenses        
Selling, general and administrative expenses 2,197 3,381 7,003 8,466
Internal research and development expenses 5 15 32 38
Total operating expenses 2,202 3,396 7,035 8,504
Loss from operations (881) (2,211) (4,513) (6,581)
Interest expense, net (67) (20) (212) (49)
Foreign exchange gain (loss) 2 0 0 (9)
Total other expense, net (65) (20) (212) (58)
Loss from operations before income tax provision (946) (2,231) (4,725) (6,639)
Income tax provision 0 (1) (2) (3)
Net loss (946) (2,232) (4,727) (6,642)
Less: Net income (loss) attributable to noncontrolling interest 430 (187) 1,208 (187)
Net loss attributable to common stockholders $ (1,376) $ (2,045) $ (5,935) $ (6,455)
Basic and diluted loss per share $ (0.15) $ (0.22) $ (0.64) $ (0.70)
Weighted average number of common and common equivalent shares outstanding – basic and diluted 9,207,874 9,207,874 9,207,874 9,165,844